What smart money is saying about CONMED
CNMD
No fund has written a full thesis on CONMED in our archive, but 2 fund letters report a position in it — most recently Tributary Capital Management Small Cap Equity Strategy in June 2026.
Get an email when a fund writes about it
2
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Every position in CONMED on record in the archive was reported in Q2 2026, across 2 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 2 | 0 | 0 | 0 |
Fund activity · 2 positions
- June 2026
“CONMED is expected to report a year-over-year revenue decline resulting from a recent divestiture, and Integer Holdings lowered its fiscal year 2026 revenue guidance, citing slower-than-expected growth in pulse field ablation products, causing shares of both companies to contract.”
CONMED - June 2026
“Health Care, Consumer Discretionary, and Industrials holdings such as CONMED, Gildan Activewear, and Armstrong World Industries also lagged their benchmark sector constituents.”
CONMED
Read the letters behind these CONMED positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger